T1	Participants 98 120	ventricular arrhythmia
T2	Participants 177 281	18 adult patients (7 women and 11 men) aged 50 +/- 7 in double-blind, placebo-controlled crossover trial
T3	Participants 393 534	patients with more than 100 premature ventricular contractions (PVC) per hour in two 24 hour Holter records obtained at an interval of 7 days
T4	Participants 2064 2115	population with a low risk of serious rhythm events
